ResMed (RMD) Announces Positive Data from HOT-HMV Study in NIV
- Futures edge lower as focus turns to Fed meeting
- BOJ hikes interest rates for first time in 17 years, to remain accommodative
- Buy the dip in US stocks in case of a 'rate shock' - Goldman
- Shares dip, yen slides as BOJ's landmark policy shift draws eyes
- Nvidia unveils Blackwell, AI chip 'to power this new industrial revolution'
- After-hours movers: ANSYS, National CineMedia, and more
- Midday movers: Google, Pepsi rise; Boeing, Zillow fall
- Midday movers: Adobe, Zillow fall; Micron rises
- After-hours movers: Adobe Systems slumps; Rivian, Ulta Beauty gain
- Midday movers: Tesla, Nvidia fall premarket; Robinhood, Dollar General rise
ResMed Expands COPD Offering as New Data Reveals Benefits of Home Non-Invasive Ventilation
September 6, 2016 1:00 AM EDTNew research released at European Respiratory Society (ERS) International Congress 2016 highlights the benefits of home non-invasive ventilation (NIV), with the potential to positively impact current practice and improve the lives of patients with COPD ResMed at-home COPD management portfolio now includes portable oxygen therapy, alongside home NIV and remote monitoring technology
LONDON--(BUSINESS WIRE)-- Today ResMed welcomed positive results from the independent Home Oxygen Therapy- Home Mechanical Ventilation (HOT-HMV) study1 regarding the benefits of home non-invasive ventilation (NIV). Portable oxygen therapy, remote monitoring technology and home NIV are... More